News Search Results
Mar 12, 2025, 07:45 ET QurAlis Announces Topline Data From its Phase 1 Clinical Trial of QRL-101 Evaluating Biomarkers of ALS and Epilepsy in Healthy Volunteers
QurAlis Corporation ("QurAlis"), a clinical-stage biotechnology company driving scientific breakthroughs into powerful precision medicines that have the potential to alter the trajectory of neurodegenerative
More news about: QurAlis
Mar 12, 2025, 06:18 ET Waterdrop Inc. Announces Fourth Quarter and Fiscal Year 2024 Unaudited Financial Results and a Cash Dividend
clinical trial solution income represents the service income earned from our customers mainly including biopharmaceutical companies and leading biotechnology companies. We match qualified and suitable patients for enrollment in clinical trials for our customers and generate digital clinical trial solution
More news about: Waterdrop Inc.
Mar 12, 2025, 06:00 ET SKYLINEDX ANNOUNCES NEW STUDY DEMONSTRATING ENHANCED RISK STRATIFICATION FOR SENTINEL LYMPH NODE BIOPSY IN HEAD AND NECK MELANOMA USING THE ADVANCED MERLIN CP-GEP TEST
diagnostic service providers globally to bring this test to market and increase patient access. About SkylineDx SkylineDx is a biotechnology company focused on research & development of molecular diagnostics in oncology inflammatory, and infectious diseases. SkylineDx uses its expertise
More news about: SkylineDx
Mar 12, 2025, 05:45 ET Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of April 11, 2025 in ICON Lawsuit - ICLR
insufficient to shield the Company from the adverse effects of a significant market downturn; (c) the requests for proposals ICON received from its biotechnology customers during the Class Period were used in substantial part as price discovery tools, and thus were not indicative of underlying client demand;
More news about: Levi & Korsinsky, LLP
Mar 12, 2025, 05:30 ET Turacoz Group Leads the Future of Evidence Synthesis With AI-Powered Living Systematic Reviews at World Evidence, Pricing and Access (EPA) Congress, Europe 2025
complex healthcare landscapes, demonstrating the value and impact of medical interventions. Committed to innovation, Turacoz empowers pharmaceutical, biotechnology, and healthcare stakeholders to make data-driven decisions that enhance patient outcomes, improve healthcare efficiencies, and optimize market access
More news about: Turacoz Healthcare BV
Mar 12, 2025, 05:30 ET Turacoz Group Leads the Future of Evidence Synthesis With AI-Powered Living Systematic Reviews at World Evidence, Pricing and Access (EPA) Congress, Europe 2025
complex healthcare landscapes, demonstrating the value and impact of medical interventions. Committed to innovation, Turacoz empowers pharmaceutical, biotechnology, and healthcare stakeholders to make data-driven decisions that enhance patient outcomes, improve healthcare efficiencies, and optimize market access
More news about: Turacoz Healthcare BV
Mar 12, 2025, 05:00 ET Pierre Fabre Laboratories and RedRidge Bio Announce a Drug Discovery and Co-development Partnership
"Pierre Fabre Laboratories are excited to enter into this agreement with RedRidge, which confirms our commitment to collaborate with innovative biotechnology companies. This partnership will allow us to capitalize on RedRidge's cutting-edge expertise in biparatopic antibody drug discovery to deliver high
More news about: Pierre Fabre Laboratories
Mar 12, 2025, 05:00 ET Pierre Fabre Laboratories and RedRidge Bio Announce a Drug Discovery and Co-development Partnership
"Pierre Fabre Laboratories are excited to enter into this agreement with RedRidge, which confirms our commitment to collaborate with innovative biotechnology companies. This partnership will allow us to capitalize on RedRidge's cutting-edge expertise in biparatopic antibody drug discovery to deliver high
More news about: Pierre Fabre Laboratories
Mar 12, 2025, 00:41 ET Harbour BioMed Launches Élancé Therapeutics to Advance Next-Generation Obesity Therapies
www.harbourbiomed.com. About Élancé Therapeutics Élancé Therapeutics is a biotechnology company developing next-generation biologics for obesity treatment. Incubated by Harbour BioMed, Élancé Therapeutics leverages advanced bispecific
More news about: Harbour BioMed
Mar 11, 2025, 22:50 ET Regeneron Science Talent Search 2025 Awards More Than $1.8 Million to High School Seniors for Innovative Research on Classifying Celestial Objects, Treating a Rare Muscle Disease and Solving a Long-Standing Math Problem
us on Facebook, Twitter, Instagram and Snapchat (Society4Science). About Regeneron Regeneron (NASDAQ: REGN) is a leading biotechnology company that invents, develops and commercializes life-transforming medicines for people with serious diseases. Founded and led by physician-scientists,
More news about: Society for Science
Mar 11, 2025, 17:46 ET TAGRISSO Sets the Stage for Market Leadership in Oncology with Strong Growth Prospects | DelveInsight
(quaratusugene ozeplasmid) (Genprex), PT-112 (Promontory Therapeutics), HMBD-001 (Hummingbird Bioscience), PLB1004 (Avistone Biotechnology), Carotuximab (ENV-105) (Kairos Pharma), and others. To know more about the number of competing drugs in development, visit @
More news about: DelveInsight Business Research, LLP
Mar 11, 2025, 17:31 ET BREYANZI Demonstrates Continued Growth in the Competitive CAR-T Market | DelveInsight
Immunitas Therapeutics (IMT-009), Monte Rosa Therapeutics (MRT-2359), SymBio Pharmaceuticals (Brincidofovir (SyB V-1901)), AVM Biotechnology (AVM0703), Autolus Therapeutics (Obecabtagene Autoleucel (Obe-cel), AUTO3), Kymera Therapeutics (KT-413), Otsuka Pharmaceutical
More news about: DelveInsight Business Research, LLP
Mar 11, 2025, 13:10 ET ICLR ANNOUNCEMENT: Kessler Topaz Meltzer & Check, LLP Notifies Investors of a Class Action Lawsuit Against ICON Public Limited Company (ICLR)
insufficient to shield the company from the adverse effects of a significant market downturn; (3) the requests for proposals ICON received from its biotechnology customers during the Class Period were used in substantial part as price discovery tools, and thus were not indicative of underlying client demand;
More news about: Kessler Topaz Meltzer & Check, LLP
Mar 11, 2025, 11:00 ET Ultima Genomics Announces Linda Ramirez as Chief Legal Officer
will join the Company as Chief Legal Officer. Linda has nearly 30 years of experience practicing law, with over a decade in the life sciences and biotechnology industry. Before joining Ultima, Linda was the General Counsel of Olink, a leading provider of next-generation proteomics solutions. Linda led Olink
More news about: Ultima Genomics
Mar 11, 2025, 10:53 ET Innovative STEM Teachers from Schools Nationwide Join the Vernier Trendsetters Community
STEM teacher at Map Academy Charter School in Plymouth, MARandy Booth, biotechnology, chemistry, and physics teacher at Itineris Early College High School in West Jordan, UTJennifer
More news about: Vernier Science Education
Mar 11, 2025, 10:00 ET Robotic Radiotherapy Market is expected to generate a revenue of USD 2.95 Billion by 2032, Globally, at 11.6% CAGR: Verified Market Research®
Global Biotechnology Contract Manufacturing (Biopharmaceutical Manufacturing) Market Size by Service (Formulation & Fill-finish, Manufacturing, Packaging &
More news about: Verified Market Research
Mar 11, 2025, 09:20 ET WuXi XDC and AbTis Announce Strategic Partnership to Advance Next-Generation ADCs
conjugates (ADCs) and other bioconjugates (XDCs), today announced the signing of a Memorandum of Understanding (MOU) with AbTis, a leading ADC biotechnology company based in South Korea. This partnership brings together AbTis' proprietary site-selective conjugation platform
More news about: WuXi XDC
Mar 11, 2025, 09:00 ET Centivax and Emery Pharma Partner to Accelerate Universal Vaccine Clinical Readiness
FRANCISCO, Calif., March 11, 2025 /PRNewswire/ -- Centivax, a biotechnology company that develops broad-spectrum vaccines to combat rapidly evolving pathogens, has announced a strategic collaboration with Emery Pharma, a
More news about: Centivax
Mar 11, 2025, 08:46 ET Culture Summit Abu Dhabi Returns Under the Theme 'Culture for Humanity and Beyond'
a confident future. Day two will explore, 'the new frontiers of a post-human environment'. As advancements in technology, including AI, biotechnology, and environmental studies redefine the essence of humanity, the sessions on this day will examine how culture can ensure these changes enhance
More news about: Department of Culture and Tourism - Abu Dhabi
Mar 11, 2025, 08:45 ET In preparation of Phase II studies, Right Brain Bio signs Manufacturing Agreement with Suven Pharmaceuticals for RB-190 to Target the Root Cause of Parkinson's Disease
March 11, 2025 /PRNewswire/ -- Right Brain Bio, a biotechnology company pioneering treatments for complex diseases, today announced a manufacturing agreement with Suven Pharmaceuticals, a technology-driven global
More news about: Right Brain Bio, Inc.
Mar 11, 2025, 08:41 ET Culture Summit Abu Dhabi Returns Under the Theme 'Culture for Humanity and Beyond'
a confident future. Day two will explore, 'the new frontiers of a post-human environment'. As advancements in technology, including AI, biotechnology, and environmental studies redefine the essence of humanity, the sessions on this day will examine how culture can ensure these changes enhance
More news about: Department of Culture and Tourism - Abu Dhabi
Mar 11, 2025, 08:34 ET Dongguk University Researchers Create Clove Essential Oil-Based Pickering Emulsions
breakthrough, a team of researchers led by Jun-Won Kang, an Assistant Professor in the Department of Food Science and Biotechnology at Dongguk University, has come up with a novel clove essential oil-based Pickering emulsion formulation with enhanced antibacterial properties.
More news about: Dongguk University
Mar 11, 2025, 08:03 ET Integral Molecular Launches Paratope-PLUS™, a CDR-Scanning Service to Support Robust Patent Claims and Antibody Engineering
Nature Biotechnology1.
More news about: Integral Molecular
Mar 11, 2025, 08:00 ET ReParris Launches to Pioneer Regenerative Therapies for Age-Related Diseases, Addressing a $7 Trillion Healthcare Crisis
model for human longevity interventions. This program could accelerate clinical insights and de-risk future human trials.The longevity biotechnology market is projected to reach
More news about: ReParris
Mar 11, 2025, 08:00 ET WearOptimo Introduces World-Class Advisory Board to Further Advance Microwearable Sensor Technology for Precision Health Monitoring
Microwearable sensors for hydration and biomarker monitoring, today introduced its Advisory Board comprised of globally recognized experts in biotechnology, healthcare, regulatory affairs, and venture investment.
More news about: WearOptimo